Skip to main content
. Author manuscript; available in PMC: 2022 Oct 3.
Published in final edited form as: Cancer. 2021 May 5;127(16):2954–2965. doi: 10.1002/cncr.33589

Figure 4.

Figure 4.

Kaplan-Meier curves illustrate overall survival (OS) in Black patients (black curve) and White patients (gray curve) who had metastatic, castrate-resistant prostate cancer and received treatment with abiraterone acetate plus prednisone. Median OS estimates are shown with 95% CIs. The graph is for illustrative purposes only; the study was not powered for cohort comparisons. Any comparison is for hypothesis generation only. NR indicates not reached.